Low-Intensity Statins
|
Moderate-Intensity Statins
|
High-Intensity Statins
|
daily dose lowers LDL by < 30%
|
lowers LDL by 30 – 50%
|
lowers LDL by ≥ 50%
|
Pravastatin 10 – 20 mg
Lovastatin 20 mg
Simvastatin 10 mg
Fluvastatin 20 – 40 mg
Pitavastatin 1 mg
|
Simvastatin 20 – 40 mg
Lovastatin 40 mg
Atorvastatin 10 (20) mg
Rosuvastatin 10 (5) mg
Pravastatin 40 (80) mg
Fluvastatin 40 mg BID
Pitavastatin 2 – 4 mg
|
Atorvastatin 40 – 80 mg
Rosuvastatin 20 (40) mg
|
Bold = evaluated in RCT, Italics = FDA approved doses but not studied
|
Four Statin Benefit Groups:
- Clinical ASCVD = acute coronary syndromes or history of MI, TIA, stroke, angina, coronary or other arterial revascularization, or peripheral arterial disease
2. Individuals with primary elevations of LDL ≥190 mg/dL
3. Individuals 40 to 75 years of age with diabetes and LDL 70 to 189 mg/dL without clinical ASCVD
4. Individuals without clinical ASCVD or diabetes who are 40 to 75 years of age and have LDL 70 to 189 mg/dL and an estimated 10-year ASCVD risk of ≥7.5%. This requires a clinician-patient discussion.
Stone NJ, et al. 2013 ACC/AHA Blood Cholesterol Guideline. Circulation. Published online 12 Nov 2013.
No comments:
Post a Comment